|
ViroTech LLC specializes in diagnosis, prognosis and therapy of cancers of the breast, ovary, uterine and vulva in women and prostate and testicular cancer in men. The company is using its proprietary technology, which is based on discovery of some unique cancer antigens and cancer genes ( RAK markers), which seem to belong to a new cancer virus and therefore, are completely absent in normal healthy tissues. During 10 years of pre-clinical and clinical studies, specificity and sensitivity of cancer detection while using the new tumor markers RAK reached 95-100%, surpassing any existing cancer detection systems.
Activity:
Product / Technology type(s) covered:
- Bio
- Technology
Therapeutic targets:
- Genetics
- Men's Health
- Women's Health
|
|